✦ LIBER ✦

Phase IB and pharmacological study of the novel taxane BMS-184476 in combination with doxorubicin

✍ Scribed by C. Sessa; A. Perotti; E. Salvatorelli; G. Minotti; L. Viganò; A. Lladò; G. Capri; A. Locatelli; S. Colombini; F. Peccatori; M. Voi; S. Marsoni; L. Gianni

Book ID: 116428061
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 221 KB
Volume: 40
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2003.11.023

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I and pharmacologic study of the

A phase I and pharmacologic study of the combination of bortezomib and pegylated liposomal doxorubicin in patients with refractory solid tumors

✍ E. Claire Dees; Bert H. O’Neil; Celeste M. Lindley; Frances Collichio; Lisa A. C 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 527 KB

A phase I and pharmacologic study of the

A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors

✍ A. S. T. Planting; P. Sonneveld; A. van der Gaast; A. Sparreboom; M. E. L. van d 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 253 KB

Novel strategy to restore the activity o

Novel strategy to restore the activity of taxanes: a multicenter phase II study of combination therapy with taxanes and toremifene at 120 mg for advanced/recurrent breast cancer. (Kinki Multidisciplinary Breast Oncology Group: KMBOG0612)

✍ Takahiro Nakayama; Takashi Arai; Jun Yamamura; Takashi Morimoto; Yoshifumi Komoi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Phase I and pharmacological study of the

Phase I and pharmacological study of the farnesyltransferase inhibitor tipifarnib (Zarnestra®, R115777) in combination with gemcitabine and cisplatin in patients with advanced solid tumours

✍ Siegel-Lakhai, W S; Crul, M; Zhang, S; Sparidans, R W; Pluim, D; Howes, A; Solan 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 121 KB

Phase II Study of the Safety and Antitum

Phase II Study of the Safety and Antitumor Activity of the Hypoxia-Activated Prodrug TH-302 in Combination With Doxorubicin in Patients With Advanced Soft Tissue Sarcoma

✍ Chawla, S. P.; Cranmer, L. D.; Van Tine, B. A.; Reed, D. R.; Okuno, S. H.; Butry 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 598 KB

A phase I study of bortezomib in combina

A phase I study of bortezomib in combination with doxorubicin and intermediate-dose dexamethasone (iPAD therapy) for relapsed or refractory multiple myeloma

✍ Yasushi Takamatsu; Kazutaka Sunami; Hiroyuki Hata; Koji Nagafuji; Ilseung Choi; 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 167 KB